Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK, Safety and Food Effect of Gemigliptin in Healthy Chinese Subjects
NCT03864432Phase 1Completed
- Sponsor
- LG Chem
- Start
- Jul 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of gemigliptin in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by LG Chem. Primary endpoints: Area Under the Curve from time zero to the last measurable concentration at 72 hours and Maximum Plasma Concentration at 72 hours. Started Jul 2019; status: completed.
02
Drugs
gemigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03864432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03864432.